First Header Logo Second Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Shapiro, Michael
Item TypeName
Academic Article Application of PCSK9 Inhibitors in Practice: Challenges and Opportunities.
Academic Article Targeting PCSK9 for therapeutic gains.
Academic Article Relationship Between Low-Density Lipoprotein Cholesterol and Lipoprotein(a) Lowering in Response to PCSK9 Inhibition With Evolocumab.
Academic Article Impact of PCSK9 inhibitors on plasma lipoprotein(a) concentrations with or without a background of niacin therapy.
Academic Article PCSK9 and Atherosclerosis - Lipids and Beyond.
Academic Article Dyslipidaemia: The PCSK9 adventure - humanizing extreme LDL lowering.
Academic Article Discordant response of low-density lipoprotein cholesterol and lipoprotein(a) levels to monoclonal antibodies targeting proprotein convertase subtilisin/kexin type 9.
Academic Article Application of PCSK9 Inhibitors in Practice.
Academic Article The PCSK9 revolution: Current status, controversies, and future directions.
Academic Article PCSK9 Association With Lipoprotein(a).
Academic Article Future role of proprotein convertase subtilisin/kexin type 9 inhibitors in preventive cardiology.
Academic Article Diagnosing Resistance to a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor.
Academic Article PCSK9: From Basic Science Discoveries to Clinical Trials.
Academic Article PCSK9 Inhibitors in Secondary Prevention-An Opportunity for Personalized Therapy.
Academic Article Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9.
Search Criteria
  • Proprotein Convertase 2